Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Biomarkers for triple negative breast cancer

A triple-negative breast cancer, biomarker technology, applied in the field of biomarkers, can solve problems such as poor prognosis and survival rate, lack of

Inactive Publication Date: 2015-03-25
ERASMUS UNIV MEDICAL CENT ROTTERDAM ERASMUS MC
View PDF0 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Women with triple-negative subtypes of breast cancer have poor prognosis and survival compared with other subtypes due to the aggressive nature of these tumors and the current lack of suitable targets for treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomarkers for triple negative breast cancer
  • Biomarkers for triple negative breast cancer
  • Biomarkers for triple negative breast cancer

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043] definition

[0044] For the purposes of the present invention, a biomarker may be a protein or nucleic acid encoding a protein, a peptide or a metabolite. Preferred biomarkers according to the invention and / or embodiments thereof are proteins, peptides or nucleic acids encoding proteins. Most preferred biomarkers according to the invention and / or embodiments thereof are proteins or peptides and / or fragments of said proteins and / or peptides.

[0045] The present invention and embodiments thereof relate to biomarkers detectable in biological samples. The biological sample may optionally consist of breast tissue, blood, lymph, serum, urine, circulating cancer cells, and / or nipple discharge.

[0046] For the present invention, poor prognosis was defined as the occurrence of distant metastases within 5 years of diagnosis.

[0047] Good prognosis was defined as freedom from metastasis within 5 years of diagnosis.

[0048] Survival increases are based on Kaplan Meier survi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to biomarkers that are useful in the prognosis of triple negative breast cancer patients. The biomarkers may be used to select treatment and to determine whether a treatment is effective or not. The biomarkers may also be used to select novel treatments and to screen for new potential compounds that may treat the triple negative breast cancer.

Description

technical field [0001] The present invention relates to biomarkers for determining the prognosis of triple negative breast cancer. The present invention further relates to methods for determining the treatment of triple-negative breast cancer and / or determining the effect of treatment on triple-negative breast cancer and screening compounds for triple-negative breast cancer. Background technique [0002] Breast cancer affects 1 in 8 women during their lifetime and is responsible for approximately 458,000 deaths worldwide each year. Most tumor cells are usually derived from the epithelium lining the milk ducts or lobules. Histopathological parameters such as tumor grade, stage, and lymph node or distant metastasis have become the gold standard for predicting prognosis. Breast cancer is a very heterogeneous disease, composed of different molecular subtypes. Molecular subtypes of breast cancer defined by gene expression profiles were first described a decade ago as biologica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574C12Q1/68
CPCC12Q1/6886C12Q2600/118C12Q2600/158G01N33/57415G01N2500/04G01N2800/52
Inventor 阿尔祖·奥马尔约翰内斯·艾伯特·弗肯斯
Owner ERASMUS UNIV MEDICAL CENT ROTTERDAM ERASMUS MC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com